Studies |
Country and Year |
Study Design |
Abstract vs Full Text |
Patient Category |
Settings |
Sample Size |
Type of ECLS |
Anticoagulation Strategies |
Outcome Definitions |
Circuit Lifespan |
Bleeding |
Thrombocytopenia |
Hypotension |
Mortality |
Arcangeli et al., 2010 [22] |
Italy, dates not available |
Prospective randomized study |
Full text |
Adults with acute renal failure |
Adult |
21 patients and 21 filters |
CRRT |
PgI2 vs heparin |
Increase of TMP above 240 mmHg, without parallel venous pressure increase |
No data reported |
No data reported |
Decrease in MAP of 10% from the baseline |
No data reported |
Balik et al., 2005 [27] |
Australia, dates not available |
comparative study |
Full text |
Adults |
Adult ICU |
33 patients and 95 circuits |
CRRT |
PgI2+heparin vs citrate |
Elevation of TMP above 200 mm Hg without parallel elevation of venous pressure |
Not available |
Platelet count less than 80,000 |
Decrease in MAP of 10% of baseline |
ICU mortality |
Birnbaum et al., 2007 [23] |
Germany, dates not available |
Prospective randomized pilot study |
Full text |
Adults with acute renal failure |
Adult ICU |
20 patients and 20 circuits |
CRRT |
Heparin vs combined heparin+PgI2 |
Filter clotting determined by visual evidence of clotting or steady increase of TMP up to 200 cmH2O. |
Not available |
Platelet count less than 30,000 |
Not available |
ICU mortality |
Brookes-Elbaz et al., 2017 [29] |
UK, dates not available |
Retrospective |
Conference paper |
Adults with AKI including cardiac (non-ECMO) cases |
Adult ICU |
240 circuits |
CRRT |
Citrate vs heparin vs PgI2 |
Not available |
Not available |
No data reported |
No data reported |
No data reported |
Davenport et al., 1994 [20] |
UK, dates not available |
prospective |
Full text |
Adult patients with combined acute hepatic and renal failure who were at risk of hemorrhage |
Adult ICU |
17 patients and 65 circuits |
CRRT |
PgI2 vs heparin |
Not available |
Hemorrhage that required blood transfusion |
Decreased platelet count |
Not available |
Not available |
Fabbri et al., 2010 [28] |
Italy, dates not available |
Prospective randomized controlled pilot study |
Full text |
Critically ill adults with acute renal failure |
Adult ICU |
90 patients |
CRRT |
Heparin+PgI2 vs heparin |
TMP is 250 mmHg and/or blood flow was halted by visible clotting |
Severe bleeding: requiring more than 4 units of blood products, or retroperitoneal, intracranial, intraocular, or resulting in death. All other bleeding were considered minimal to moderate. |
Not available |
Not available |
Not available |
Goonasekera et al., 2015 [30] |
UK, dates not available |
Prospective |
Conference paper |
Pediatric acute liver failure patients |
PICU |
71 patients |
CRRT |
PgI2 vs heparin |
Not available |
Not available |
Platelet consumption and need for platelet transfusion |
Requirement for fluids/vasopressors |
Not available |
Herrera-Gutiérrez et al., 2006 [32] |
Spain, 1994 |
Prospective |
Full text |
Adults with acute renal failure |
Adult ICU |
389 patients and 1873 circuits |
CRRT |
PgI2 vs heparin |
Not available |
No data reported |
No data reported |
No data reported |
No data reported |
Hutchison et al., 2016 [24] |
UK, dates not available |
Prospective |
Conference paper |
Adults requiring CRRT with no contraindication for regional citrate anticoagulation |
Adult ICU |
53 patients and 172 circuits |
CRRT |
Citrate vs PgI2 |
Not available |
No data reported |
No data reported |
No data reported |
No data reported |
Journois et al., 1990 [19] |
France, dates not available |
Retrospective |
Full text |
Adults with acute renal failure |
Adult ICU |
9 patients and 36 circuits |
CRRT |
Heparin vs PgI2+Enoxaparin |
Time to reach a third of initial membrane permeability |
No data reported |
Not available |
No data reported |
No data reported |
Kozek-Langenecker et al., 2002 [17] |
Austria, dates not available |
double-blinded RCT |
Full text |
Adults requiring RRT secondary to sepsis or major surgery |
Adult ICU |
50 patients and 210 circuits |
CRRT |
Heparin+PgI2 vs heparin+ PgE1 |
Not available |
Significant bleeding is the occurrence of bleeding requiring transfusion of blood products, other types of bleeding considered trivial |
No data reported |
No data reported |
No data reported |
Lasorella et al., 2014 [26] |
UK, dates not available |
Prospective |
Conference paper |
Children with acute liver failure |
PICU |
108 patients |
CRRT |
PgI2 vs heparin |
Not available |
Not available |
platelet consumption |
requirement for fluids/vasopressors |
Not available |
Ostermann et al., 2010 [16] |
UK, 2008-2009 |
Retrospective |
Conference paper |
Adults requiring CRRT |
Adult ICU |
288 circuitsepisodes |
CRRT |
Heparin vs PgI2 vs combined hepain/PgI2 |
Not available |
No data reported |
No data reported |
No data reported |
No data reported |
Poply et al., 2014 [21] |
UK, dates not available |
retrospective |
Conference paper |
Adults with AKI |
Mixed ICU |
26 patients and 50 circuits |
CRRT |
Heparin vs PgI2 vs no anticoagulation |
Not available |
Not available |
Platelet less than 80 |
No data reported |
No data reported |
Seller-Perez et al., 2009 [25] |
Spain, dates not available |
prospective |
Conference paper |
|
Adult ICU |
43 patients and 43 circuits |
MARS |
Mixed protocol vs PgI2 vs no anticoagulation |
Not available |
Not available |
No data reported |
No data reported |
No data reported |
Tovey et al., 2013 [18] |
UK, 2008-2009 |
Retrospective |
Full text |
Adults with severe AKI requiring CRRT |
Adult ICU |
309 patients and 2059 circuits |
CRRT |
Heparin vs PgI2 vs citrate |
Premature filter clotting excluding elective discontinuation |
No data reported |
No data reported |
No data reported |
No data reported |
Windelov et al., 2010 [31] |
Denmark, 2009-2008 |
retrospective |
Full text |
Adults with AKI requiring CRRT |
Adult ICU |
94 patients |
CRRT |
Heparin vs PgI2 |
No data reported |
No data reported |
Not available |
No data reported |
Mortality at 30, 90, and 365 days |